APA (7th ed.) Citation

Bozorgmehr, F., Chung, I., Fischer, J. R., Bischof, M., Atmaca, A., Wetzel, S., . . . Rieken, S. (2025). Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: Results from the FORCE phase II trial (AIO/YMO-TRK-0415). Clinical & experimental metastasis, 42(5), . https://doi.org/10.1007/s10585-025-10358-x

Chicago Style (17th ed.) Citation

Bozorgmehr, Farastuk, et al. "Reconsidering Palliative Radiotherapy in Addition to PD-1 Blockade for Non-small Cell Lung Cancer: Results from the FORCE Phase II Trial (AIO/YMO-TRK-0415)." Clinical & Experimental Metastasis 42, no. 5 (2025). https://doi.org/10.1007/s10585-025-10358-x.

MLA (9th ed.) Citation

Bozorgmehr, Farastuk, et al. "Reconsidering Palliative Radiotherapy in Addition to PD-1 Blockade for Non-small Cell Lung Cancer: Results from the FORCE Phase II Trial (AIO/YMO-TRK-0415)." Clinical & Experimental Metastasis, vol. 42, no. 5, 2025, https://doi.org/10.1007/s10585-025-10358-x.